Documented 0 10 0 10 O
history 11 18 11 18 O
of 19 21 19 21 O
≥1 22 24 22 24 O
symptomatic 25 36 25 36 B-clinical_variable
hyperammonemia 37 51 37 51 I-clinical_variable
event 52 57 52 57 O
with 58 62 58 62 O
ammonia 63 70 63 70 B-clinical_variable
≥100 71 75 71 75 O
µmol 76 80 76 80 I-lower_bound
/ 80 81 80 81 I-lower_bound
L 81 82 81 82 I-lower_bound

History 0 7 83 90 O
of 8 10 91 93 O
liver 11 16 94 99 B-chronic_disease
disease 17 24 100 107 I-chronic_disease

Liver 0 5 108 113 B-treatment
transplant 6 16 114 124 I-treatment
, 16 17 124 125 O
including 18 27 126 135 O
hepatocyte 28 38 136 146 B-treatment
cell 39 43 147 151 I-treatment
therapy 44 51 152 159 I-treatment
/ 51 52 159 160 I-treatment
transplant 52 62 160 170 I-treatment

Males 0 5 171 176 B-gender

Males 0 5 177 182 B-gender
and 6 9 183 186 I-gender
all 10 13 187 190 I-gender
females 14 21 191 198 I-gender
of 22 24 199 201 O
childbearing 25 37 202 214 O
potential 38 47 215 224 O
must 48 52 225 229 O
be 53 55 230 232 O
willing 56 63 233 240 B-contraception_consent
to 64 66 241 243 I-contraception_consent
use 67 70 244 247 I-contraception_consent
effective 71 80 248 257 I-contraception_consent
contraception 81 94 258 271 I-contraception_consent
at 95 97 272 274 O
the 98 101 275 278 O
time 102 106 279 283 O
of 107 109 284 286 O
administration 110 124 287 301 O
of 125 127 302 304 O
gene 128 132 305 309 O
transfer 133 141 310 318 O
and 142 145 319 322 O
for 146 149 323 326 O
the 150 153 327 330 O
52 154 156 331 333 O
weeks 157 162 334 339 O
following 163 172 340 349 O
administration 173 187 350 364 O
of 188 190 365 367 O
DTX301 191 197 368 374 O

On 0 2 375 377 O
stable 3 9 378 384 O
dose 10 14 385 389 O
of 15 17 390 392 O
ammonia 18 25 393 400 B-treatment
scavenger 26 35 401 410 I-treatment
therapy 36 43 411 418 I-treatment
for 44 47 419 422 O
≥4 48 50 423 425 O
weeks 51 56 426 431 I-lower_bound

Participation 0 13 432 445 O
in 14 16 446 448 O
another 17 24 449 456 B-treatment
investigational 25 40 457 472 I-treatment
medicine 41 49 473 481 I-treatment
study 50 55 482 487 I-treatment
( 56 57 488 489 I-treatment
including 57 66 489 498 I-treatment
another 67 74 499 506 I-treatment
gene 75 79 507 511 I-treatment
transfer 80 88 512 520 I-treatment
trial 89 94 521 526 I-treatment
) 94 95 526 527 I-treatment
within 96 102 528 534 O
3 103 104 535 536 B-upper_bound
months 105 111 537 543 I-upper_bound
of 112 114 544 546 O
Screening 115 124 547 556 O

Serum 0 5 557 562 B-clinical_variable
creatinine 6 16 563 573 I-clinical_variable
> 17 18 574 575 O
2.0 18 21 575 578 B-lower_bound
mg 22 24 579 581 I-lower_bound
/ 24 25 581 582 I-lower_bound
dL 25 27 582 584 I-lower_bound

Subject 0 7 585 592 O
's 7 9 592 594 O
OTC 10 13 595 598 B-chronic_disease
deficiency 14 24 599 609 I-chronic_disease
is 25 27 610 612 O
stable 28 34 613 619 O

an 0 2 620 622 O
ammonia 3 10 623 630 B-clinical_variable
level 11 16 631 636 I-clinical_variable
< 17 18 637 638 O
100 18 21 638 641 B-upper_bound
µmol 22 26 642 646 I-upper_bound
/ 26 27 646 647 I-upper_bound
L 27 28 647 648 I-upper_bound
within 29 35 649 655 O
the 36 39 656 659 O
4 40 41 660 661 B-upper_bound
week 42 46 662 666 I-upper_bound
period 47 53 667 673 O
preceding 54 63 674 683 O
the 64 67 684 687 O
Screening 68 77 688 697 O
visit 78 83 698 703 O

females 0 7 704 711 B-gender

no 0 2 712 714 O
clinical 3 11 715 723 O
symptoms 12 20 724 732 O
of 21 23 733 735 O
hyperammonemia 24 38 736 750 B-chronic_disease

with 0 4 751 755 O
documented 5 15 756 766 O
diagnosis 16 25 767 776 O
of 26 28 777 779 O
late 29 33 780 784 O
onset 34 39 785 790 O
( 40 41 791 792 O
defined 41 48 792 799 O
as 49 51 800 802 O
first 52 57 803 808 O
manifestation 58 71 809 822 O
of 72 74 823 825 O
signs 75 80 826 831 O
and 81 84 832 835 O
symptoms 85 93 836 844 O
at 94 96 845 847 O
≥1 97 99 848 850 O
month 100 105 851 856 I-lower_bound
of 106 108 857 859 O
age 109 112 860 863 B-age
) 112 113 863 864 O
OTC 114 117 865 868 B-chronic_disease
deficiency 118 128 869 879 I-chronic_disease
, 128 129 879 880 O
confirmed 130 139 881 890 O
via 140 143 891 894 O
enzymatic 144 153 895 904 B-treatment
, 153 154 904 905 O
biochemical 155 166 906 917 B-treatment
, 166 167 917 918 O
or 168 170 919 921 O
molecular 171 180 922 931 B-treatment
testing 181 188 932 939 I-treatment

≥18 0 3 940 943 O
years 4 9 944 949 I-lower_bound
of 10 12 950 952 O
age 13 16 953 956 B-age

